The British firm currently has actually 3 accepted signs for the medication mepolizumab in China.
发布者：BY ALBERT RONNING-ANDERSSON，转转请注明出处：https://robotalks.cn/gsk-receives-chinese-approval-for-chronic-rhinosinusitis-treatment/
GSK receives Chinese approval for chronic rhinosinusitis treatment
赞 (0)
关于作者
Eli Lilly set to join FDA in lawsuit over copycat weight-loss drugs
上一篇
4 1 月, 2025 4:23 上午
Regeneron acquires UK biotech company
下一篇
4 1 月, 2025 4:23 上午
相关推荐
-
Trump’s deep-sea EO causes a splash
The United States is getting along with DSM as a response to its important mineral issues .
-
The secret to effective tailings management
Dam’s international supervisor of tailings and backfill on remedies for tasks of all dimensions .
-
Skyportz and FlyNow Aviation partner to develop vertiports designed for eCopter operations
Skyportz and FlyNow Air Travel, maker of the eCopter– a portable, low-noise electrical air taxi created for city freight and traveler transportation– have actually reve…
-
Following XRP’s 50,000% Historical Gains, Market Analysts Highlight UNIL as a Strong Candidate for the Next Major Parabolic Move
The XRP price has continued to draw attention from analysts after its historic 50,000% rally. Recent research notes that some analysts are now looking at other platforms. They beli…
